Cushing Syndrome Clinical Trial
Official title:
The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
The investigators will conduct a prospective study, in which they will determine sensitivity, specificity and diagnostic accuracy of late evening urinary free cortisol concentration/creatinine and hair cortisol in differentiating Cushing's syndrome from Pseudo-Cushing's syndrome.
24h-Urine free cortisol (24h-UFC) and other screening tests may turn out normal in Cushing's
syndrome (CS) patients, probably due to high variability and cyclicity in cortisol secretion.
To rule out cyclic cortisol secretion, the recommendation is to repeat 24h-UFC measurements
on different and several occasions. As 24h-UFC is technically inconvenient, especially in the
elderly and in women, compliance may not be optimal, and results could be falsely low
especially if collection is not properly conducted.
Alternatively, the status of cortisol circadian rhythm and urinary cortisol secretion may be
assessed in a non-invasive and more convenient manner through the measurement of late evening
urinary free cortisol concentration/creatinine concentration (Late-UFC). These measurements
have been useful in screening outpatients for CS, but their performances have not been
properly and enough validated.
It appears that the assessment of Late-UFC can offer a non-invasive and convenient diagnostic
tool for evaluating cortisol circadian rhythm and urinary cortisol secretion in ambulatory
populations, especially in the case of patients for whom 24h-UFC should be repeated yet is
technically not convenient to perform.
Hair sample testing has gained increasing attention and recognition over the last 20 years,
especially for detecting illegal drug use and for other forensic purposes. This is because
hair provides a relatively long-term retrospective record of levels of various bio-markers in
the body.
In light of the foregoing evidence, it has been suggested that hair cortisol measurement
could be a novel method for assessing dynamic systemic cortisol exposure, and could provide
unique historical information on variation and cyclicity in cortisol exposure.
The investigators will conduct a prospective cohort study which will include patients
referred to outpatient endocrinology clinic for medical evaluation due to CS suspicion or
adrenal incidentaloma evaluation. Participants will be asked to provide informed consent
before study enrollment. All Participants will be asked to perform the routine screening
tests for CS diagnosis. On the same day participants will collect the 24h-UFC, they will be
asked to empty their urinary bladder at 22:00 hour to the urinary collection bottle, and to
give a single urinary sample at 24:00 hour for Late-UFC determination.
Immediately after study enrollment, hair sample of approximately 100-150 strands and 2-3 cm
long will be collected from the posterior vertex, and cortisol concentration in hair will be
determined.
All patients enrolled will be diagnosed as "CS", "Pseudo-Cushing's syndrome" or "undermined".
CS will be classified as ACTH-dependent CS or ACTH-independent CS. ACTH-dependent CS will be
diagnosed when at least two screening tests for CS are positive (not including Late-UFC and
HC), normal or elevated basal plasma ACTH concentration, and positive ACTH stained histology
and/or post-surgical hypoadrenalism. ACTH-independent CS will be diagnosed when at least one
screening test is positive, depressed basal plasma ACTH concentration (ACTH concentration
below 2.2 pmol/L) and the patient has adrenal-post-surgical hypoadrenalism. Patients will be
diagnosed as "Pseudo-Cushing's syndrome" when only one screening test is positive out of at
least three tests performed, patients harboring no typical features for CS, and there is no
deterioration in biochemical or clinical status during the study follow-up. Patients will be
diagnosed as "undermined" when harboring two or more positive screening tests, yet the
clinical and biochemical profile do not support definitive diagnosis.
To address the questions of the study, the investigators will compare the two groups of "CS"
and "Pseudo-Cushing's syndrome" determining sensitivity, specificity and diagnostic accuracy
of Late-UFC and Hair cortisol in differentiating Cushing's syndrome from Pseudo-Cushing's
syndrome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06050057 -
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
|
||
Recruiting |
NCT05881005 -
NAC- NAFLD And Cushing
|
N/A | |
Recruiting |
NCT00669266 -
Adrenal Tumors - Pathogenesis and Therapy
|
||
Terminated |
NCT03379363 -
Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
|
||
Recruiting |
NCT06008184 -
Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids
|
||
Recruiting |
NCT05911620 -
Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism
|
N/A | |
Completed |
NCT02934399 -
Dynamic Hormone Diagnostics in Endocrine Disease
|
||
Recruiting |
NCT04045015 -
Liquorice and Salivary Cortisol
|
N/A | |
Recruiting |
NCT05804669 -
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT03474237 -
A Prospective Cohort Study for Patients With Adrenal Diseases
|
||
Recruiting |
NCT03343470 -
The Circadian Rhythm in CusHing SyndrOme in Active Phase and dUring RemiSsion (TheHOURS)
|
||
Recruiting |
NCT03364803 -
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
|
||
Terminated |
NCT02001051 -
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
|
Phase 2 | |
Completed |
NCT03697109 -
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
|
Phase 3 | |
Enrolling by invitation |
NCT03604198 -
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
|
Phase 2 | |
Completed |
NCT05347979 -
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT01382420 -
Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma
|
N/A | |
Completed |
NCT00001849 -
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
|
Phase 2 | |
Recruiting |
NCT06229405 -
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data
|
||
Recruiting |
NCT03211624 -
Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome
|